Small Cap📈 ASX
Medical Developments International Limited (ASX: MVP)
Published 9 June 2026Healthcare Pulse Report
Medical Developments International Limited
ASX: MVP
Medical Developments International Limited develops and supplies innovative pharmaceutical solutions alongside medical and veterinary devices. Its flagship pain relief product, Penthrox, underpins its healthcare portfolio, which is marketed across Australia, Europe, and Asia. Founded in 1971 and headquartered in Scoresby, the company has b
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Healthcare Pulse Report
A$1200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Healthcare Pulse Report
Stay informed on Australia's healthcare sector with expert research covering healthcare, biotechnology, medical technology, and life sciences companies listed on the ASX.
- ✓ ASX Healthcare & Biotech Research
- ✓ Delivered Fortnightly every 2nd & 4th Tuesday
- ✓ Industry Trends & Risk Analysis
- ✓ Full Historical Report Access
A$1200.00/ 12 months
Risk:High
Subscribe Now →